Standard of care medications GSK study Chronic Coronary Heart Disease NCT00799903

Standard of care medications
Descripción

Standard of care medications

1. Was the subject regularly taking STATIN therapy for 8 weeks or more prior to randomisation?
Descripción

STATIN therapy prior to randomisation

Tipo de datos

boolean

2. Was the subject taking STATIN therapy at the time of randomisation?
Descripción

STATIN therapy at randomisation

Tipo de datos

boolean

If no, indicate reason
Descripción

no STATIN therapy at randomisation reason

Tipo de datos

text

If other reason, specify:
Descripción

no STATIN therapy at randomisation other reason

Tipo de datos

text

3. Was the subject regularly taking ASPIRIN therapy for 8 weeks or more prior to randomisation?
Descripción

ASPIRIN therapy prior to randomisation

Tipo de datos

boolean

4. Was the subject taking ASPIRIN at the time of randomisation?
Descripción

ASPIRIN at randomisation

Tipo de datos

boolean

If no, indicate reason:
Descripción

no ASPIRIN at randomisation reason

Tipo de datos

text

If other reason, specify:
Descripción

no ASPIRIN at randomisation other reason

Tipo de datos

text

5. Is the subject regularly taking any P2Y12 inhibitors (i.e. thienopyridines)?
Descripción

P2Y12 inhibitors

Tipo de datos

boolean

If no, indicate reason:
Descripción

no P2Y12 inhibitors reason

Tipo de datos

text

If other reason, specify:
Descripción

no P2Y12 inhibitors other reason

Tipo de datos

text

6. Is the subject taking a beta-blocker?
Descripción

beta-blocker

Tipo de datos

boolean

If no, indicate reason:
Descripción

no beta-blocker reason

Tipo de datos

text

If other reason, specify:
Descripción

no beta-blocker other reason

Tipo de datos

text

7. Is the subject taking an ACE inhibitor?
Descripción

ACE inhibitor

Tipo de datos

boolean

If no, indicate reason:
Descripción

no ACE inhibitor reason

Tipo de datos

text

If other reason, specify:
Descripción

no ACE inhibitors other reason

Tipo de datos

text

8. Is the subject taking an ARB?
Descripción

ARB

Tipo de datos

boolean

If no, indicate reason:
Descripción

no ARB reason

Tipo de datos

text

If other reason, specify:
Descripción

no ARB other reason

Tipo de datos

text

9. Is the subject taking any other renin-angiotensin-aldosterone system-targeted medication?
Descripción

renin-angiotensin-aldosterone system-targeted medication

Tipo de datos

boolean

If no, indicate reason:
Descripción

no renin-angiotensin-aldosterone system-targeted medication reason

Tipo de datos

text

If other reason, specify:
Descripción

no renin-angiotensin-aldosterone system-targeted medication other reason

Tipo de datos

text

Similar models

Standard of care medications GSK study Chronic Coronary Heart Disease NCT00799903

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Standard of care medications
STATIN therapy prior to randomisation
Item
1. Was the subject regularly taking STATIN therapy for 8 weeks or more prior to randomisation?
boolean
STATIN therapy at randomisation
Item
2. Was the subject taking STATIN therapy at the time of randomisation?
boolean
Item
If no, indicate reason
text
Code List
If no, indicate reason
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
Item
If other reason, specify:
text
Code List
If other reason, specify:
ASPIRIN therapy prior to randomisation
Item
3. Was the subject regularly taking ASPIRIN therapy for 8 weeks or more prior to randomisation?
boolean
ASPIRIN at randomisation
Item
4. Was the subject taking ASPIRIN at the time of randomisation?
boolean
Item
If no, indicate reason:
text
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
no ASPIRIN at randomisation other reason
Item
If other reason, specify:
text
P2Y12 inhibitors
Item
5. Is the subject regularly taking any P2Y12 inhibitors (i.e. thienopyridines)?
boolean
Item
If no, indicate reason:
text
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no P2Y12 inhibitors other reason
Item
If other reason, specify:
text
beta-blocker
Item
6. Is the subject taking a beta-blocker?
boolean
Item
If no, indicate reason:
text
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no beta-blocker other reason
Item
If other reason, specify:
text
ACE inhibitor
Item
7. Is the subject taking an ACE inhibitor?
boolean
Item
If no, indicate reason:
text
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no ACE inhibitors other reason
Item
If other reason, specify:
text
ARB
Item
8. Is the subject taking an ARB?
boolean
Item
If no, indicate reason:
text
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no ARB other reason
Item
If other reason, specify:
text
renin-angiotensin-aldosterone system-targeted medication
Item
9. Is the subject taking any other renin-angiotensin-aldosterone system-targeted medication?
boolean
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no renin-angiotensin-aldosterone system-targeted medication other reason
Item
If other reason, specify:
text